These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6498387)

  • 41. Prognostic trees to aid prognosis in patients with cutaneous malignant melanoma. Scottish Melanoma Group.
    Aitchison TC; Sirel JM; Watt DC; MacKie RM
    BMJ; 1995 Dec; 311(7019):1536-9; discussion 1539-41. PubMed ID: 8520396
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Using a continuous transformation of the Breslow thickness for prognosis in cutaneous melanoma.
    Vollmer RT; Seigler HF
    Am J Clin Pathol; 2001 Feb; 115(2):205-12. PubMed ID: 11211608
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survival from invasive cutaneous malignant melanoma in Western Australia and the Oxford Region: a comparative histological study of high and low incidence populations.
    Heenan PJ; Holman CD
    Pathology; 1983 Apr; 15(2):147-52. PubMed ID: 6888961
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor Thickness and Modified Clark Level in Canine Cutaneous Melanocytic Tumors.
    Silvestri S; Porcellato I; Mechelli L; Menchetti L; Rapastella S; Brachelente C
    Vet Pathol; 2019 Mar; 56(2):180-188. PubMed ID: 30244658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surgical treatment and survival from cutaneous malignant melanoma.
    Heenan PJ; Weeramanthri T; Holman CD; Armstrong BK
    Aust N Z J Surg; 1985 Jun; 55(3):229-34. PubMed ID: 3863576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognosis of primary melanoma.
    Ilmonen S; Asko-Seljavaara S; Kariniemi AL; Jeskanen L; Pyrhönen S; Muhonen T
    Scand J Surg; 2002; 91(2):166-71. PubMed ID: 12164517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disease progression in patients with thin cutaneous melanomas (tumour thickness < or = 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977-98.
    Schmid-Wendtner MH; Baumert J; Eberle J; Plewig G; Volkenandt M; Sander CA
    Br J Dermatol; 2003 Oct; 149(4):788-93. PubMed ID: 14616371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thin malignant melanomas (less than 1.5 mm) with metastasis: a histological study and survival analysis.
    Blessing K; McLaren KM; McLean A; Davidson P
    Histopathology; 1990 Nov; 17(5):389-95. PubMed ID: 2076865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical correlates of Breslow thickness of malignant melanoma.
    Osborne JE; Hutchinson PE
    Br J Dermatol; 2001 Mar; 144(3):476-83. PubMed ID: 11260002
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cutaneous melanoma of the head and neck.
    Vreeburg GC; Schouwenburg PF; Hilgers FJ; de Kraker NW; Hart AA
    Eur J Surg Oncol; 1988 Apr; 14(2):165-70. PubMed ID: 3360158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A retrospective study of 275 cases of cutaneous malignant melanoma in the East Midland region.
    Bos MY; Deane M
    Br J Plast Surg; 1982 Jan; 35(1):60-2. PubMed ID: 7066588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Malignant melanoma in life insurance--thickness or anatomic layer?].
    Müller WA; Erlanger M
    Versicherungsmedizin; 1994 Dec; 46(6):193-5. PubMed ID: 7825264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The relationship between risk of death from clinical stage 1 cutaneous melanoma and thickness of primary tumour: no evidence for steps in risk. Scottish Melanoma Group.
    Keefe M; Mackie RM
    Br J Cancer; 1991 Sep; 64(3):598-602. PubMed ID: 1911205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regression in malignant melanoma. A histologic feature without independent prognostic significance.
    Kelly JW; Sagebiel RW; Blois MS
    Cancer; 1985 Nov; 56(9):2287-91. PubMed ID: 4052972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognosis of thick cutaneous melanoma of the trunk and extremity.
    Coit D; Sauven P; Brennan M
    Arch Surg; 1990 Mar; 125(3):322-6. PubMed ID: 2306180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thin level IV malignant melanoma. A subset in which level is the major prognostic indicator.
    Kelly JW; Sagebiel RW; Clyman S; Blois MS
    Ann Surg; 1985 Jul; 202(1):98-103. PubMed ID: 4015217
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic factors in the treatment of cutaneous melanoma.
    Breslow A
    J Cutan Pathol; 1979 Jun; 6(3):208-12. PubMed ID: 479439
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Malignant melanoma of the foot. A clinicopathological study of 125 primary cutaneous malignant melanomas.
    Søndergaard K; Olsen G
    Acta Pathol Microbiol Scand A; 1980 Sep; 88(5):275-83. PubMed ID: 7468216
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Malignant melanoma of the skin: prognostic value of histology in 89 cases.
    Williams WJ; Davies K; Jones WM; Roberts MM
    Br J Cancer; 1968 Sep; 22(3):452-60. PubMed ID: 5681005
    [No Abstract]   [Full Text] [Related]  

  • 60. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
    de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.